SCHEMBL22097012

SCHEMBL22097012

c1ccc(-c2nc(-c3ccc(-c4ccncc4)cc3)nc(-c3ccc(-c4ccc5c(c4)c4ccccc4c4ccc6c7ccccc7n(-c7ccccc7)c6c45)cc3)n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
HSP90AA1 P07900 1/20 0.39
KDM4E B2RXH2 1/20 0.37
ATM Q13315 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
MKNK1 Q9BUB5 1/20 0.36
PIK3CA P42336 3/20 0.36
PIK3CD O00329 2/20 0.36
PIK3CB P42338 2/20 0.36
MTOR P42345 2/20 0.36
PIK3CG P48736 2/20 0.36
NPC1 O15118 1/20 0.35
NFKB1 P19838 1/20 0.35
RAB9A P51151 1/20 0.35
NFKB2 Q00653 1/20 0.35
RELA Q04206 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22096967 0.98 MAPT (0.39) MAPTMEN1KMT2AHSP90AA1KDM4E
SCHEMBL22097118 0.95 MAPT (0.37) MAPTMEN1KMT2AHSP90AA1KDM4E
SCHEMBL22097262 0.92 L3MBTL1 (0.41) MAPTMEN1KMT2AHSP90AA1KDM4E
SCHEMBL22097203 0.92 L3MBTL1 (0.41) MAPTMEN1KMT2AHSP90AA1KDM4E
SCHEMBL22097074 0.91 L3MBTL1 (0.42) MAPTMEN1KMT2AKDM4EATM
SCHEMBL22097075 0.91 L3MBTL1 (0.42) MAPTMEN1KMT2AKDM4EATM
SCHEMBL22097130 0.87 GRM5 (0.37) MAPTMEN1KMT2AKDM4EATM
SCHEMBL22097133 0.87 MAPT (0.37) MAPTMEN1KMT2AHSP90AA1KDM4E
SCHEMBL22097236 0.87 MAPT (0.39) MAPTMEN1KMT2AHSP90AA1KDM4E
SCHEMBL22097107 0.86 MEN1 (0.40) MAPTMEN1KMT2AKDM4EATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11236075-B2 Organic compound and organic electroluminescence device using the same LUMINESCENCE TECHNOLOGY CORP. (TW) 2022-02-01 US disclosed
US-20200190065-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2020-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11236075-B2 Organic compound and organic electroluminescence device using the same ICMT, OR10J3, PIEZO1 MAPT 508/4885MEN1 1207/4885KMT2A 2500/4885
US-20200190065-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME ICMT, OR10J3, PIEZO1 MAPT 508/4885MEN1 1207/4885KMT2A 2500/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.